Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastomaRobert S. McNeill, C. Ryan Miller, Timothy J. Stuhlmiller et al.|Neuro-Oncology|2017Cited by 63